Beck Mack & Oliver’s Amgen AMGN Stock Holding History

Beck Mack & Oliver’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Sell	624 -4,438	-88%	-$1.58M	﹤0.01%	181
2025 Q4	$1.66M	Buy	5,062 +33	+0.7%	+$10.5K	0.03%	98
2025 Q3	$1.42M	Buy	5,029 +37	+0.7%	+$10.7K	0.03%	96
2025 Q2	$1.39M	Buy	4,992 +87	+2%	+$24.6K	0.03%	95
2025 Q1	$1.53M	Buy	4,905 +282	+6%	+$83.3K	0.03%	92
2024 Q4	$1.21M	Buy	4,623 +34	+0.7%	+$10.1K	0.02%	96
2024 Q3	$1.48M	Buy	4,589 +20	+0.4%	+$6.54K	0.03%	92
2024 Q2	$1.43M	Buy	4,569 +1	+0%	+$294	0.03%	92
2024 Q1	$1.3M	Buy	4,568 +89	+2%	+$26K	0.03%	101
2023 Q4	$1.29M	Buy	+4,479	New	+$1.22M	0.03%	96
2022 Q2	–	Sell	-4,200	Closed	-$1.02M	–	174
2022 Q1	$1.02M	Hold	4,200	–	–	0.03%	116
2021 Q4	$945K	Hold	4,200	–	–	0.02%	120
2021 Q3	$893K	Sell	4,200 -8	-0.2%	-$1.84K	0.02%	120
2021 Q2	$1.03M	Buy	4,208 +8	+0.2%	+$1.97K	0.03%	109
2021 Q1	$1.04M	Sell	4,200 -1,000	-19%	-$239K	0.03%	108
2020 Q4	$1.2M	Hold	5,200	–	–	0.04%	100
2020 Q3	$1.32M	Hold	5,200	–	–	0.05%	95
2020 Q2	$1.23M	Hold	5,200	–	–	0.05%	96
2020 Q1	$1.05M	Sell	5,200 -180	-3%	-$39.3K	0.05%	96
2019 Q4	$1.3M	Hold	5,380	–	–	0.04%	101
2019 Q3	$1.04M	Sell	5,380 -20	-0.4%	-$3.84K	0.04%	108
2019 Q2	$995K	Hold	5,400	–	–	0.04%	109
2019 Q1	$1.03M	Hold	5,400	–	–	0.04%	111
2018 Q4	$1.05M	Sell	5,400 -800	-13%	-$156K	0.04%	108
2018 Q3	$1.28M	Hold	6,200	–	–	0.04%	112
2018 Q2	$1.14M	Hold	6,200	–	–	0.04%	114
2018 Q1	$1.06M	Hold	6,200	–	–	0.04%	114
2017 Q4	$1.08M	Hold	6,200	–	–	0.04%	117
2017 Q3	$1.16M	Hold	6,200	–	–	0.04%	114
2017 Q2	$1.07M	Sell	6,200 -400	-6%	-$65.1K	0.04%	112
2017 Q1	$1.08M	Sell	6,600 -2,750	-29%	-$457K	0.04%	109
2016 Q4	$1.37M	Sell	9,350 -2,750	-23%	-$414K	0.05%	102
2016 Q3	$2.02M	Hold	12,100	–	–	0.07%	92
2016 Q2	$1.84M	Hold	12,100	–	–	0.07%	111
2016 Q1	$1.81M	Sell	12,100 -2,500	-17%	-$371K	0.06%	111
2015 Q4	$2.37M	Sell	14,600 -200	-1%	-$31.4K	0.08%	98
2015 Q3	$2.05M	Hold	14,800	–	–	0.06%	116
2015 Q2	$2.27M	Sell	14,800 -260	-2%	-$41.6K	0.06%	110
2015 Q1	$2.41M	Hold	15,060	–	–	0.06%	111
2014 Q4	$2.4M	Sell	15,060 -113	-0.7%	-$17.6K	0.06%	109
2014 Q3	$2.13M	Sell	15,173 -2,700	-15%	-$353K	0.05%	116
2014 Q2	$2.12M	Buy	17,873 +260	+1%	+$30.1K	0.05%	121
2014 Q1	$2.17M	Hold	17,613	–	–	0.05%	115
2013 Q4	$2.01M	Sell	17,613 -1,337	-7%	-$152K	0.05%	122
2013 Q3	$2.12M	Hold	18,950	–	–	0.06%	116
2013 Q2	$1.87M	Buy	+18,950	New	+$1.97M	0.05%	119

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Beck Mack & Oliver's AMGN Position: Q1 2026 in Review

Beck Mack & Oliver reduced its Amgen (AMGN) stake by 88% in Q1 2026, selling an estimated $1.58M and leaving 624 shares worth $220K. The position accounts for ﹤0.01% of the portfolio, ranked #181.

Beck Mack & Oliver first reported a position in AMGN in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.41M in Q1 2015. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Beck Mack & Oliver held 624 shares of Amgen worth $220K as of Q1 2026.
Beck Mack & Oliver sold 4,438 Amgen shares in Q1 2026, an estimated $1.58M.
Amgen made up ﹤0.01% of Beck Mack & Oliver's portfolio in Q1 2026, its #181 holding.
Beck Mack & Oliver first reported a position in Amgen in Q2 2013 and has held it in 46 quarters since.
Beck Mack & Oliver's Amgen position peaked at $2.41M in Q1 2015.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Beck Mack & Oliver's 13F filing for Q1 2026, filed 12 May 2026.